EUVIMEDEUVIMED entdecken
Leserbrief

Non-insulin diabetes medicines: an emerging role in pain management? Comment on Br J Anaesth 2025; 135: 898–911

Antonio Alcántara Montero

British Journal of Anaesthesia · 2026-01 · 136 (1) · 427-428

DOI: 10.1016/j.bja.2025.10.010 ↗

Kurz gefasst

Leserbrief in der Zeitschrift British Journal of Anaesthesia, 2026-01. Verfasst von Antonio Alcántara Montero. Beteiligte Einrichtung: Centro de Salud Trujillo, Trujillo (Cáceres), Spain. Electronic address: a.alcantara.montero@hotmail.com. Die Arbeit nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

DPP-4 inhibitorsGLP-1 receptor agonistsSGLT2 inhibitorsanalgesiachronic paindiabetes mellitusnon-insulin antidiabetic agents

Autor:innen und Institutionen

  • Centro de Salud Trujillo, Trujillo (Cáceres), Spain. Electronic address: a.alcantara.montero@hotmail.com.

Zitieren

APA

Alcántara Montero, A. (2026). Non-insulin diabetes medicines: an emerging role in pain management? Comment on Br J Anaesth 2025; 135: 898–911. British Journal of Anaesthesia, 136(1), 427-428. https://doi.org/10.1016/j.bja.2025.10.010

Vancouver

Alcántara Montero A. Non-insulin diabetes medicines: an emerging role in pain management? Comment on Br J Anaesth 2025; 135: 898–911. British Journal of Anaesthesia. 2026;136(1):427-428. doi:10.1016/j.bja.2025.10.010

BibTeX
@article{AlcntaraMontero2026,
  author = {Alcántara Montero, Antonio},
  title = {Non-insulin diabetes medicines: an emerging role in pain management? Comment on Br J Anaesth 2025; 135: 898–911},
  journal = {British Journal of Anaesthesia},
  year = {2026},
  volume = {136},
  number = {1},
  pages = {427--428},
  doi = {10.1016/j.bja.2025.10.010}
}
Kostenlos starten →